The specific reactive oxygen and nitrogen species (RONS) that are generated during CHCP treatment that induces TNF-alpha expression in turn regulating BCL2A1 expression in the above breast cancer cells is a detailed stand-alone study by itself. This evidence concerns the gene BCL2A1 and breast carcinoma.